LSI Interviews Rob Ball and Dave Blue
Rob Ball and David Blue were recently interviewed by Scott Pantel of LSI, sharing about their experience at the 2020 LSI conference which helped forge a connection that led to …
We partner with innovators who create medical devices that improve the value of healthcare
Genesis is an early stage investor in medical device technology. We are differentiated through our deep level of engagement in delivering value through all stages of the commercialization process. This is accomplished by leveraging the time, talent, and financial resources of the Genesis Innovation Group Portfolio.
Step 1:
This is where we find and create the concepts that represent the beginnings of solutions to unsolved problems.
Through the smart deployment of talent and resources, we confirm or query whether further investment is a great opportunity.
Step 2:
Launching a company isn’t easy.
Fortunately, we have the talent, experience, and know-how to turn fully developed innovations into valuable assets.
Step 3:
Great ideas are just the beginning.
Further investment in the best of our innovations and findings at the early stages can lead to outsized returns due to our highly operational engagement.
With more than 200 patents and innovations among its founders, Genesis Innovations Group is a leader in medical device development and commercialization.
The cultivate(MD) model is already yielding a harvest, with multiple products entering the market.
Genesis Innovation Group is continuously seeking and investigating medical device technologies where our team can complement the creation of value. We are focused on early stage where our team can add value through addition of technical competence, talented team members, and financial resources.
Built on trust, with a long history of successful ventures
Genesis played an integral role in developing the strategy for my company. Together with additional investment of time, talent, and money by Genesis, Imascap has grown beyond my expectations.
Wakestream has invested along side Genesis in two of their portfolio companies because we have come to appreciate the depth of experience of the talent at Genesis and their highly innovative approach to business.
I sought to leverage the value of my IP for years and struggled to get traction. Genesis engaged my project and within a year they did everything they said they would do, and the result was everything I hoped.
One of the best compliments I can say about Genesis is they have done every aspect of medical startup business, and succeeded at it, multiple times. Their professionalism throughout the vetting process was so far superior to any other group we had worked with. Genesis’ unique approach to investing comes from wearing every hat in the process, allowing them to know exactly where you are, where you want to go, and how to get there. It has been a pleasure working with them.
After being here (2019 The State of Spine Surgery Think Tank) I’m even more glad to have partnered with Genesis. Your connections, experience, and overall perspective is perfect.
Rob Ball and David Blue were recently interviewed by Scott Pantel of LSI, sharing about their experience at the 2020 LSI conference which helped forge a connection that led to …
cultivate(MD)’s Seed Funds have demonstrated strong progress and performance, and it is now time to launch our new Accelerator Fund. This fund is born out of the significant advancements that …
Novel radial artery occlusion device removes the guesswork from achieving Patent Hemostasis Holland, Mich. – December 9th, 2020 – Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused …